Bernstein raises Cameco stock price target to $98 on nuclear renaissance

Published 09/10/2025, 14:08
Bernstein raises Cameco stock price target to $98 on nuclear renaissance

Investing.com - Bernstein SocGen Group raised its price target on Cameco Corporation (NYSE:CCJ) to $98.00 from $74.00 on Thursday, while maintaining an Outperform rating on the uranium producer’s stock. The company, currently valued at $37.58 billion, has demonstrated remarkable momentum with a 115% surge over the past six months. According to InvestingPro analysis, Cameco is currently trading above its Fair Value.

The significant price target increase reflects Bernstein’s confidence in the long-term nuclear renaissance theme, with the firm citing "strong evidence of demand" in the sector.

Bernstein specifically pointed to the continuing ramp of new builds, small modular reactor (SMR) developments, and pro-nuclear leadership changes expected in 2025 in both the United States and Japan as supporting factors.

The nuclear and uranium sector has significantly outperformed the broader market year-to-date, with various ETFs focused on the theme nearly doubling in value, according to Bernstein’s analysis.

Bernstein’s updated price target, which stands 11% above consensus and represents 15% upside potential, incorporates Canadian dollar market adjustments, a shift from 2026 to 2027 projections, and improved future margins based on fixed costs and cash cost growth control.

In other recent news, Cameco Corporation has been the focus of several analyst reports and strategic developments. BMO Capital increased its price target for Cameco to Cdn$120, maintaining an Outperform rating, even as the company flagged a significant reduction in McArthur River production guidance. Meanwhile, CLSA initiated coverage of Cameco with an Outperform rating and a price target of $102, citing expanding nuclear energy demand as a positive factor for the uranium producer. Goldman Sachs also initiated coverage with a Buy rating, highlighting the positive sentiment toward nuclear growth under the current administration. Additionally, Bernstein reiterated an Outperform rating with a $74 price target, emphasizing Cameco’s stake in next-generation laser enrichment as a strategic asset.

In related developments, uranium stocks, including Cameco, saw a rise following U.S. Energy Secretary David Wright’s announcement of plans to increase the national strategic uranium stockpile. This announcement led to a 7% advance in Cameco’s stock, reflecting the broader positive outlook for uranium stocks. These recent developments underscore the growing interest and potential in the nuclear energy sector, with Cameco positioned as a key player.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.